Advocacy Services

Overview

CortexBio's advocacy services bridge the crucial gap between pharmaceutical and biotech companies with patient communities, creating meaningful partnerships that drive innovation and improve outcomes. Our approach extends beyond traditional engagement to establish authentic collaborations that amplify patient voices throughout the entire drug development lifecycle.

Our Approach

We recognise that patient advocacy has evolved from a peripheral activity to a central component of successful therapeutic development. Our team applies specialised expertise to:

·      Strategic Advocacy Planning: Develop comprehensive patient engagement strategies tailored to your specific therapeutic area, company culture, and development stage.

·      Patient Organisation Mapping: Identify and connect with the most relevant patient organisations for your therapeutic focus, creating opportunities for meaningful collaboration and partnerships.

·      Coalition Building: Facilitate connections between stakeholders, including researchers, clinicians, regulatory bodies, and patient advocates, to create robust ecosystems of support.

Benefits

·      Enhanced clinical trial design and recruitment through patient-informed protocols

·      Improved regulatory submissions with authentic patient experience data

·      Stronger market positioning through a deep understanding of patient needs

·      Development of trusted, long-term relationships with patient communities

Why CortexBio

Our unique integrative approach to rare and metabolic diseases positions us to understand the full spectrum of stakeholder needs. Dr. Martini-Drew's extensive experience in both rare diseases and ageing research provides a distinctive lens through which we view advocacy—connecting patient communities across traditionally siloed therapeutic areas.